Journal of Internal Medicine Concepts & Practice ›› 2024, Vol. 19 ›› Issue (01): 25-31.doi: 10.16138/j.1673-6087.2024.01.05
• Experts forum • Previous Articles Next Articles
JIE Zhijun, SHA Jiafeng, ZHANG Meng
Received:
2023-09-19
Online:
2024-02-29
Published:
2024-04-28
CLC Number:
JIE Zhijun, SHA Jiafeng, ZHANG Meng. Reinfection of COVID-19 and response[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(01): 25-31.
[1] | WHO. WHO coronavirus (COVID-19) dashboard[EB/OL]. 2023. https://covid19.who.int/. |
[2] | WHO. COVID-19 epidemiological update - 24 November 2023[EB/OL]. 2023. https://www.who.int/publications/m/item/covid-19-epidemiological-update---24-november-2023 |
[3] |
Klaassen F, Chitwood MH, Cohen T, et al. Changes in population immunity against infection and severe disease from severe acute respiratory syndrome coronavirus 2 omicron variants in the United States between December 2021 and November 2022[J]. Clin Infect Dis, 2023, 77(3): 355-361.
doi: 10.1093/cid/ciad210 URL |
[4] | Bastard J, Taisne B, Figoni J, et al. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022[J]. Euro Surveill, 2022, 27(13):2200247. |
[5] |
Guedes AR, Oliveira MS, Tavares BM, et al. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic[J]. Sci Rep, 2023, 13(1): 712.
doi: 10.1038/s41598-022-25908-6 pmid: 36639411 |
[6] | Eythorsson E, Runolfsdottir HL, Ingvarsson RF, et al. Rate of SARS-CoV-2 reinfection during an Omicron wave in iceland[J]. JAMA Netw Open, 2022, 5(8):e2225320. |
[7] | 戴映雪, 王瑶, 杜训波, 等. 成都市新冠病毒既往感染者重复感染Omicron变异株情况分析[J]. 中国公共卫生, 2023, 39(4): 442-447. |
[8] |
Lin M, Cao K, Xu F, et al. A follow-up study on the recovery and reinfection of Omicron COVID-19 patients in Shanghai, China[J]. Emerg Microbes Infect, 2023, 12(2):2261559.
doi: 10.1080/22221751.2023.2261559 URL |
[9] | Yu W, Guo Y, Hu T, et al. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China[J]. J Med Virol, 2023, 95(8):e28997. |
[10] |
Wang Y, Liang J, Yang H, et al. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province[J]. Front Public Health, 2023, 11:1256768.
doi: 10.3389/fpubh.2023.1256768 URL |
[11] | Kissler SM, Hay JA, Fauver JR, et al. Viral kinetics of sequential SARS-CoV-2 infections[EB/J]. medRxiv, 2023. https://www.medrxiv.org/content/10.1101/2023.03.03.23286775v1. |
[12] | Hadley E, Yoo YJ, Patel S, et al. SARS-CoV-2 reinfection is preceded by unique biomarkers and related to initial infection timing and severity[EB/J]. medRxiv [Preprint], 2023.https://doi.org/10.1101/2023.01.03.22284042. |
[13] |
Abu-Raddad LJ, Chemaitelly H, Bertollini R. Severity of SARS-CoV-2 reinfections as compared with primary infections[J]. N Engl J Med, 2021, 385(26):2487-2489.
doi: 10.1056/NEJMc2108120 URL |
[14] |
Mensah AA, Lacy J, Stowe J, et al. Disease severity during SARS-COV-2 reinfection[J]. J Infect, 2022, 84(4):542-550.
doi: 10.1016/j.jinf.2022.01.012 URL |
[15] |
Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection[J]. Nat Med, 2022, 28(11):2398-2405.
doi: 10.1038/s41591-022-02051-3 pmid: 36357676 |
[16] |
Cavanaugh AM, Spicer KB, Thoroughman D, et al. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination - Kentucky, May-June 2021[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(32):1081-1083.
doi: 10.15585/mmwr.mm7032e1 URL |
[17] |
Gazit S, Shlezinger R, Perez G, et al. The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine[J]. Ann Intern Med, 2022, 175(5):674-681.
doi: 10.7326/M21-4130 URL |
[18] |
Hammerman A, Sergienko R, Friger M, et al. Effectiveness of the BNT162b2 vaccine after recovery from COVID-19[J]. N Engl J Med, 2022, 386(13):1221-1229.
doi: 10.1056/NEJMoa2119497 URL |
[19] | Ye C, Zhang G, Zhang A, et al. The Omicron variant reinfection risk among individuals with a previous SARS-CoV-2 infection within one year in Shanghai, China[J]. Vaccines (Basel), 2023, 11(7):1146. |
[20] |
Cerqueira-Silva T, Andrews JR, Boaventura VS, et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil[J]. Lancet Infect Dis, 2022, 22(6):791-801.
doi: 10.1016/S1473-3099(22)00140-2 pmid: 35366959 |
[21] |
COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection[J]. Lancet, 2023, 401(10379): 833-842.
doi: 10.1016/S0140-6736(22)02465-5 URL |
[22] |
Powell AA, Kirsebom F, Stowe J, et al. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022[J]. Lancet Infect Dis, 2023, 23(4):435-444.
doi: 10.1016/S1473-3099(22)00729-0 URL |
[23] |
Tan CY, Chiew CJ, Pang D, et al. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore[J]. Lancet Infect Dis, 2023, 23(7): 799-805.
doi: 10.1016/S1473-3099(23)00060-9 URL |
[24] |
Lumley SF, O'Donnell D, Stoesser NE, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers[J]. New Engl J Med, 2021, 384(6): 533-540.
doi: 10.1056/NEJMoa2034545 URL |
[25] | Finch E, Lowe R, Fischinger S, et al. SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort[J]. PLoS Biol, 2022, 20(2):e3001531. |
[26] | Michlmayr D, Hansen CH, Gubbels SM, et al. Observed protection against SARS-CoV-2 reinfection following a primary infection[J]. Lancet Reg Health Eur, 2022, 20:100452. |
[27] |
Collier DA, Ferreira IATM, Kotagiri P, et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2[J]. Nature, 2021, 596(7872):417-422.
doi: 10.1038/s41586-021-03739-1 |
[28] | Mazagatos C, Monge S, Olmedo C, et al. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021[J]. Euro Surveill, 2021, 26(24):2100452. |
[29] |
Palacios-Pedrero MÁ, Jansen JM, Blume C, et al. Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults[J]. Nat Aging, 2022, 2(10): 896-905.
doi: 10.1038/s43587-022-00292-y pmid: 37118289 |
[30] |
Li M, Peng H, Duan G, et al. Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant[J]. Front Public Health, 2022, 10:1014470.
doi: 10.3389/fpubh.2022.1014470 URL |
[31] |
Hansen CH, Michlmayr D, Gubbels SM, et al. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020[J]. Lancet, 2021, 397(10280):1204-1212.
doi: 10.1016/S0140-6736(21)00575-4 URL |
[32] | 张戈, 张安冉, 贾逸林, 等. 上海市浦东新区新冠病毒重复感染情况分析[EB/J]. 上海预防医学, 2023. https://kns.cnki.net/kcms2/article/abstract?v=smPsKIJgVaAYWg3fyvJbRxd88NUnMspFJv9V6LXB6zr56O7fU8X9zY_z9gu0Ik51p3j_gyp3zac8piy_F_GNfPIjzWO2LFZzmAOYZGc1hudgNqVcywJPPuGjKAxFH_7YyCFtLrc86OE=&uniplatform=NZKPT&language=CHS. |
[33] | Washington State Department of Health. Reported COVID-19 reinfections in Washington State[EB/OL]. 2022. https://doh.wa.gov/sites/default/files/2022-02/421-024-ReportedReinfections.pdf. |
[34] | Ferguson N, Ghani A, Cori A, et al. Growth, population distribution and immune escape of Omicron in England[EB/OL]. 2021. https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2021-12-16-COVID19-Report-49.pdf. |
[35] | Chen X, Xu Y, Xie Y, et al. Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection[J]. Lancet Reg Health West Pac, 2023, 33:100758. |
[36] | 陆婉莹, 陈鑫华, 郑楠, 等. 新型冠状病毒原型株有症状感染者中和抗体水平对奥密克戎亚型BA.1、BA.4和BA.5的保护概率预测[J]. 中华医学杂志, 2023, 103(18): 1429-1434. |
[37] |
Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Protective effect of previous SARS-CoV-2 infection against Omicron BA.4 and BA.5 subvariants[J]. N Engl J Med, 2022, 387(17):1620-1622.
doi: 10.1056/NEJMc2209306 URL |
[38] |
Chemaitelly H, Tang P, Coyle P, et al. Protection against reinfection with the Omicron BA.2.75 subvariant[J]. N Engl J Med, 2023, 388(7):665-667.
doi: 10.1056/NEJMc2214114 URL |
[39] | Chen JJ, Li LB, Peng HH, et al. Neutralization against XBB.1 and XBB.1.5 after Omicron subvariants breakthrough infection or reinfection[J]. Lancet Reg Health West Pac, 2023, 33:100759. |
[40] | Paliani U, Cardona A, Gili A, et al. Impact of rehabilitation treatment during the acute phase of SARS-CoV-2 infection[EB/J]. Eur J Intern Med, 2023. https://www.ejinme.com/article/S0953-6205(23)00415-6/abstract. |
[41] | de Araújo Furtado PL, do Socorro Brasileiro-Santos M, de Mello BLC, et al. The effect of telerehabilitation on physical fitness and depression/anxiety in post-COVID-19 patients[J]. Int J Telerehabil, 2023, 15(1):e6560. |
[42] | WHO. Support for rehabilitation: self-management after COVID-19-related illness, second edition 2021[EB/OL]. 2021. https://iris.who.int/handle/10665/344472. |
[43] | 国务院联防联控机制综合组. 《近期重点人群新冠病毒疫苗接种工作方案》解读[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202307/d5968788cfee4caf8087955d470fd306.shtml. |
[44] |
Tan ST, Kwan AT, Rodríguez-Barraquer I, et al. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave[J]. Nat Med, 2023, 29(2):358-365.
doi: 10.1038/s41591-022-02138-x pmid: 36593393 |
[45] |
Cromer D, Juno JA, Khoury D, et al. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection[J]. Nat Rev Immunol, 2021, 21(6): 395-404.
doi: 10.1038/s41577-021-00550-x pmid: 33927374 |
[1] | QIN Ye1 (秦野), CHEN Rongrong2∗ (陈蓉蓉). Social Network Analysis of COVID-19 Research and the Changing International Collaboration Structure [J]. J Shanghai Jiaotong Univ Sci, 2024, 29(1): 150-160. |
[2] | HONG Dongyang1,3 (洪冬羊), WANG Jinxia2,3 (王金霞), ZHANG Hongyang2,3 (张虹洋), CAO Ziyang2,3 (曹紫阳), YAN Zijun 2,3 (晏紫君), ZOU Lin2,3∗ (邹琳). Psychological Impact of the 2022 Round COVID-19 Pandemic on China’s College Students [J]. J Shanghai Jiaotong Univ Sci, 2024, 29(1): 141-149. |
[3] | WU Chunxiao, GU Kai, PANG Yi, WANG Chunfang, SHI Liang, XIANG Yongmei, GONG Yangming, DOU Jianming, SHI Yan, FU Chen. Incidence, mortality and survival analysis of small intestine cancer in Shanghai population-based study from 2002 to 2016 [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 240-248. |
[4] | SHI Yuling, CHEN Wenjuan. Psoriasis comorbidity: prevalence, diagnosis and treatment [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 221-229. |
[5] | LIANG Chen, YU Jiajia, TANG Shenjie. Interpretation of the Global Tuberculosis Report 2022 by World Health Organization [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 21-30. |
[6] | WANG Zezhou, ZHENG Ying. Lung cancer worldwide and in China from 1990 to 2020: prevalence and prevention measures [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 1-7. |
[7] | ZHANG Weiyu, ZHENG Lan, ZHENG Weihua, LIU Jialin, LÜ Lingling, LU Lingyun, YANG Cuiping, LI Qiong. Characteristics of traditional Chinese medicine syndromes in mild cases of coronavirus Omicron variant infection [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 48-50. |
[8] | CUI Jiasong, ZHANG Enming, WANG Suxing, GAN Lu, DAI Zhengyue, FANG Qiong. The current status of intensive care unit competency and infectious disease emergency response capability of nurses involved in the critical care of COVID-19 in Shanghai [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 43-47. |
[9] | GAO Weiling, HU Yingqing.. Effect of parental accompanying on peri-anesthesia nursing care of children with congenital ptosis under the background of COVID-19 [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(4): 339-. |
[10] | BU Ran (卜冉), XIANG Wei∗ (向伟), CAO Shitong (曹世同). COVID-19 Interpretable Diagnosis Algorithm Based on a Small Number of Chest X-Ray Samples [J]. J Shanghai Jiaotong Univ Sci, 2022, 27(1): 81-89. |
[11] | WANG Zhiming(王志明), DONG Jingjing (董静静), ZHANG Junpeng∗ (张军鹏). Multi-Model Ensemble Deep Learning Method to Diagnose COVID-19 Using Chest Computed Tomography Images [J]. J Shanghai Jiaotong Univ Sci, 2022, 27(1): 70-80. |
[12] | GAO Caihong. Analysis of therapeutic efficacy of simplified diagnosis and treatment for outpatients with acute mild ischemic stroke in designated hospitals during the COVID-19 pandemic [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 385-389. |
[13] | SHI Feng, GUO Zhuying, GUO Haiyan. Clinical significance of changes in peripheral blood lymphocyte subsets in patients with novel coronavirus pneumonia [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 619-624. |
[14] | BAO Pingping, WU Chunxiao, GU Kai, PANG Yi, WANG Chunfang, SHI Liang, XIANG Yongmei, GONG Yangming, DOU Jianming, WU Mengyin, FU Chen, SHI Yan. Analysis on incidence of stomach cancer in 2016 and trend of incidence during 2002-2016 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 462-469. |
[15] | ZHENG Yuzhen, ZHENG Yanjun, ZHOU Yi, QI Xing, CHEN Weiwei, SHI Wen, ZHOU Weijun, YANG Zhitao, CHEN Ying, MAO Enqiang, CHEN Erzhen. The clinical retrospective analysis of 674 hospitalized patients diagnosed with sepsis in a general hospital [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 278-282. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||